Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
65 64 Search
2025
The role of the endocannabinoid system in the pathogenesis and treatment of epilepsy
Reviews in the Neurosciences
2025
Molecular targets of cannabinoids and their derivatives in epilepsy – a review with focus on CBD
Acta Biochimica Polonica
2024
Transcriptomic alterations in cortical astrocytes following the development of post-traumatic epilepsy
Scientific Reports
2024
Cannabinoids and Genetic Epilepsy Models: A Review with Focus on CDKL5 Deficiency Disorder
International Journal of Molecular Sciences
2024
Unveiling the Potential of Phytocannabinoids: Exploring Marijuana’s Lesser-Known Constituents for Neurological Disorders
Biomolecules
2024
Cannabinoid treatments in epilepsy and seizure disorders
Physiological Reviews
2024
Twenty-first century antiepileptic drugs. An overview of their targets and synthetic approaches
European Journal of Medicinal Chemistry
2023
Cannabidivarin alleviates α‐synuclein aggregation viaDAF‐16 inCaenorhabditis elegans
The FASEB Journal
2023
Pre-existing Toxoplasma gondii infection increases susceptibility to pentylenetetrazol-induced seizures independent of traumatic brain injury in mice
Frontiers in Molecular Neuroscience
2023
Diastereoselective and Scalable Synthesis of 6-(S)-Hydroxycannabidivarin
The Journal of Organic Chemistry
2023
Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a+/- mouse model of Dravet syndrome
PLOS ONE
2023
The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential
Life Sciences
2022
Epilepsy progression is associated with cumulative DNA methylation changes in inflammatory genes
Progress in Neurobiology
2022
Autism and associated disorders: cannabis as a potential therapy
Frontiers in Bioscience-Elite
2022
An Analysis of Over-the-Counter Cannabidiol Products in the United Kingdom
Cannabis and Cannabinoid Research
2022
Cannabidiol Reduces Short- and Long-Term High Glutamate Release after Severe Traumatic Brain Injury and Improves Functional Recovery
Pharmaceutics
2022
Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence
International Journal of Molecular Sciences
2022
Review: Cannabinoids as Medicinals
Current Addiction Reports
2022
Anticonvulsive and anti-epileptogenesis effects of Echinacea purpurea root extract, an involvement of CB2 receptor
Journal of Complementary and Integrative Medicine
2021
Contents of Cannabinoids in Hemp Varieties Grown in Maryland
ACS Omega
2021
Ameliorating effects of histamine H3 receptor antagonist E177 on acute pentylenetetrazole-induced memory impairments in rats
Behavioural Brain Research
2021
Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses
Frontiers in Pharmacology
2021
Advances in Experimental Medicine and Biology
2021
Cannabichromene, Related Phytocannabinoids, and 5-Fluoro-cannabichromene Have Anticonvulsant Properties in a Mouse Model of Dravet Syndrome
ACS Chemical Neuroscience
2021
Protective Effects of Cannabidivarin and Cannabigerol on Cells of the Blood–Brain Barrier Under Ischemic Conditions
Cannabis and Cannabinoid Research
2021
Reduced Expression of Hippocampal GluN2A-NMDAR Increases Seizure Susceptibility and Causes Deficits in Contextual Memory
Frontiers in Neuroscience
2021
Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy
British Journal of Pharmacology
2021
Modern approaches to the development of synthetic cannabinoid receptor probes
Pharmacology Biochemistry and Behavior
2021
An Insight into Molecular Mechanisms and Novel Therapeutic Approaches in Epileptogenesis
CNS & Neurological Disorders - Drug Targets
2021
Therapeutic potential of cannabidivarin for epilepsy and autism spectrum disorder
Pharmacology & Therapeutics
2021
Advances in Experimental Medicine and Biology
2021
Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?
Frontiers in Pharmacology
2021
Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC
Biomedicines
2021
An Evaluation of Understudied Phytocannabinoids and Their Effects in Two Neuronal Models
Molecules
2020
Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol
Pharmacological Research
2020
Pharmacological potential of varinic-, minor-, and acidic phytocannabinoids
Pharmacological Research
2020
Platelets promote epileptic seizures by modulating brain serotonin level, enhancing neuronal electric activity, and contributing to neuroinflammation and oxidative stress
Progress in Neurobiology
2020
Phytocannabinoid drug-drug interactions and their clinical implications
Pharmacology & Therapeutics
2020
Development of cannabidiol as a treatment for severe childhood epilepsies
British Journal of Pharmacology
2020
Cannabis constituents reduce seizure behavior in chemically-induced and scn1a-mutant zebrafish
Epilepsy & Behavior
2020
A systematic review of minor phytocannabinoids with promising neuroprotective potential
British Journal of Pharmacology
2019
Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice
Journal of Psychopharmacology
2018
Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). II. Drugs in more advanced clinical development
Epilepsia
2018
Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis
Frontiers in Neurology
2018
A resurging boom in new drugs for epilepsy and brain disorders
Expert Review of Clinical Pharmacology
2018
Investigational small molecules in phase II clinical trials for the treatment of epilepsy
Expert Opinion on Investigational Drugs
2018
Medical Use of Cannabinoids
Drugs
2018
Determination of cannabinoids in Cannabis sativa L. samples for recreational, medical, and forensic purposes by reversed-phase liquid chromatography-ultraviolet detection
Journal of Analytical Science and Technology
2018
Investigational cannabinoids in seizure disorders, what have we learned thus far?
Expert Opinion on Investigational Drugs
2017
Do Cannabinoids Confer Neuroprotection Against Epilepsy? An Overview
The Open Neurology Journal
2017
Progress in the Chemistry of Organic Natural Products
2017
Analysis of natural product regulation of cannabinoid receptors in the treatment of human disease
Pharmacology & Therapeutics
2017
Anticonvulsive activity of (1S)-(−)-verbenone involving RNA expression of BDNF, COX-2, and c-fos
Naunyn-Schmiedeberg's Archives of Pharmacology
2017
Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII)
Epilepsia
2016
Cannabidiol and epilepsy: Rationale and therapeutic potential
Pharmacological Research
2016
Enhanced expression of immediate–early genes in mouse hippocampus after trimethyltin treatment
Acta Histochemica
2016
From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology
Physiological Reviews
2016
Methods in Pharmacology and Toxicology
2015
Maximal electroshock-induced seizures are able to induce Homer1a mRNA expression but not pentylenetetrazole-induced seizures
Epilepsy & Behavior
2015
Ultrastructural changes to rat hippocampus in pentylenetetrazol- and kainic acid-induced status epilepticus: A study using electron microscopy
Micron
2015
Progress report on new antiepileptic drugs: A summary of the Twelfth Eilat Conference (EILAT XII)
Epilepsy Research
2015
Phytocannabinoids and epilepsy
Journal of Clinical Pharmacy and Therapeutics
2015
Medicinal Plants
2015
Handbook of Experimental Pharmacology
Additional cited-by details will be shown when available from Crossref